首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Molecular Physiology of Renal Aquaporins and Sodium Transporters: Exciting Approaches to Understand Regulation of Renal Water Handling
【24h】

Molecular Physiology of Renal Aquaporins and Sodium Transporters: Exciting Approaches to Understand Regulation of Renal Water Handling

机译:肾脏水通道蛋白和钠转运蛋白的分子生理学:理解肾脏水处理法规的令人兴奋的方法

获取原文
           

摘要

The discovery of aquaporin membrane water channels by Agre and coworkers answered a long-standing biophysical question of how water crosses biologic membranes specifically, and provided insight, at the molecular level, into the fundamental physiology of water balance and the pathophysiology of water balance disorders. The importance of this achievement is underscored by awarding Peter Agre the Nobel Prize in chemistry in 2003. Of the known twelve aquaporin isoforms, at least eight are known to be present in the kidney at distinct sites along the nephron and collecting duct. AQP1 is extremely abundant in the proximal tubule and descending thin limb where it appears to be the main site for proximal nephron water reabsorption. AQP1 is also present in the descending vasa recta. AQP2 is abundant in the collecting duct principal cells and is the chief target for the regulation of collecting duct water reabsorption by vasopressin. Acute regulation involves vasopressin-induced trafficking of AQP2 between an intracellular reservoir in vesicles and the apical plasma membrane. In addition, AQP2 is involved in chronic/adaptational control of body water balance, which is achieved through regulation of AQP2 expression. Importantly, multiple studies have now underscored a critical role of AQP2 in several inherited and acquired water balance disorders. This includes inherited forms of nephrogenic diabetes insipidus, acquired states of nephrogenic diabetes insipidus, and other diseases associated with urinary concentrating defects where AQP2 expression and targeting is affected as recently reviewed (1).
机译:Agre及其同事发现了水通道蛋白膜水通道,回答了一个长期存在的关于物理上如何跨过生物膜的生物物理问题,并在分子水平上为水平衡的基本生理学和水平衡失调的病理生理学提供了见识。 2003年授予彼得·阿格里(Peter Agre)诺贝尔化学奖,突出了这一成就的重要性。已知的十二种水通道蛋白同工型中,至少有八种存在于肾脏中沿肾单位和收集管的不同部位。 AQP1在近端肾小管和下肢细小分支中非常丰富,在那里它似乎是近端肾单位水重吸收的主要部位。 AQP1也存在于降脉管直肠中。 AQP2在集管主细胞中含量丰富,是通过加压素调节集管水重吸收的主要靶标。急性调节涉及血管加压素诱导的AQP2在囊泡的细胞内储层和顶质膜之间的运输。此外,AQP2参与人体水分平衡的长期/适应性控制,这是通过调节AQP2表达来实现的。重要的是,现在有多项研究强调了AQP2在几种遗传性和获得性水平衡疾病中的关键作用。这包括遗传性肾病性尿崩症,肾病性尿崩症的获得性状态以及与尿液浓缩缺陷相关的其他疾病,如最近综述,这些疾病会影响AQP2的表达和靶向(1)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号